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Abstract
Background: Despite the major public health importance of visceral leishmaniasis (VL) in Latin America, well-designed
studies to inform diagnosis, treatment and control interventions are scarce. Few observational studies address prognostic
assessment in patients with VL. This study aimed to identify risk factors for death in children aged less than 15 years
admitted for VL treatment in a referral center in northeast Brazil.
Methodology/Principal Findings: In a retrospective cohort, we reviewed 546 records of patients younger than 15 years
admitted with the diagnosis of VL at the Instituto de Medicina Integral Professor Fernando Figueira between May 1996 and
June 2006. Age ranged from 4 months to 13.7 years, and 275 (50%) were male. There were 57 deaths, with a case-fatality
rate of 10%. In multivariate logistic regression, the independent predictors of risk of dying from VL were (adjusted OR, 95%
CI): mucosal bleeding (4.1, 1.3–13.4), jaundice (4.4, 1.7–11.2), dyspnea (2.8, 1.2–6.1), suspected or confirmed bacterial
infections (2.7, 1.2–6.1), neutrophil count ,500/mm
3 (3.1, 1.4–6.9) and platelet count ,50,000/mm
3 (11.7, 5.4–25.1). A
prognostic score was proposed and had satisfactory sensitivity (88.7%) and specificity (78.5%).
Conclusions/Significance: Prognostic and severity markers can be useful to inform clinical decisions such as whether a child
with VL can be safely treated in the local healthcare facility or would potentially benefit from transfer to referral centers
where advanced life support facilities are available. High risk patients may benefit from interventions such as early use of
extended-spectrum antibiotics or transfusion of blood products. These baseline risk-based supportive interventions should
be assessed in clinical trials.
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Introduction
In Latin America, visceral leishmaniasis (VL) cases occur from
Mexico to Argentina, but around 90% of reported cases come from
Brazil [1]. Despite substantial underreporting in several different parts
of the world [1], Brazil’s national surveillance system has informed
e s t i m a t e so fd i s e a s eb u r d e ni nt h i sc o u n t r y ,w h e r eV Lc a s e sa r ef o u n d
in the Distrito Federal and in 22 of 26 states [2]. Between 1990 and
2008 nearly 58,000 cases were reported in Brazil, but annual numbers
have increased from 1,944 cases in 1990 to 3,990 in 2008 [3]. While
the average VL incidence has been around 2 cases per 100,000
inhabitants [2], these figures do not take into account the focal nature
of disease, which selectively pose a much higher burden on neglected
populations from rural Northeast or from the slums around large
cities, where major epidemics have recently occurred [4]. Although
many infected individuals present no signs of disease, symptomatic VL
can be very severe and its mortality remains substantial. Studies held
in different parts of Brazil have reported case-fatality rates ranging
from 4.4% to 10.2% in treated patients [5–7].
Despite the major public health importance of VL in Latin
America, a recently published systematic review has shown
that well-designed studies to inform diagnosis, treatment and
control interventions in the region are scarce [8]. Unfortunately,
national guidelines and treatment recommendations are often
based on expert opinion instead of hard data from controlled
trials [9]. Moreover, few observational studies address risk
assessment in patients with the disease. For instance, as far as
prognostic indicators are concerned, published evidence tend to
come from elsewhere other than Latin America [10–13], from
where we found only one report [5]. This report from Teresina
(Brazil) identifies young age as a risk factor for poor prognosis,
but it included patients from all ages in the analysis. In pediatric
practice, however, it would be useful to identify children under
higher risk of dying so that the best supportive and therapeutic
options could be offered. The aim of the present study is to
identify risk factors for death in children under the age of 15
years admitted for VL treatment in a referral center in northeast
Brazil.
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Ethics statement
The protocol was approved by the Research Ethics Committee
of the Instituto de Medicina Integral Prof. Fernando Figueira
(IMIP). Because data were retrieved from hospital records dating
up to more than ten years and of patients whose families live away
from Recife, the Ethics Committee agreed it would not be feasible
to obtain individual signed consent forms. Data were however
analyzed anonymously.
Objectives
Socio-demographic, clinical and laboratory variables were
assessed for association with death (primary outcome) in children
and adolescents admitted for VL treatment. In addition, the study
aimed to describe the case-fatality rate and the main causes of
death in this group.
Study design and participants
A retrospective cohort of children and adolescents with up to 14
years of age (inclusive) admitted for VL treatment was carried out
at IMIP, a tertiary non-for-profit teaching hospital located in
Recife (population 1.5 million), in the northeast of Brazil. IMIP, a
referral center for the treatment of VL, belongs to the national
public health system and provides free medical care for people
from Pernambuco and neighbor states.
Patients notified to the hospital epidemiology department as
having a diagnosis of VL were considered eligible to participate in
the study and their records were reviewed, regardless of the
outcome, from admission to discharge or death. Clinical, socio-
demographic and laboratory variables were recorded onto a
standardized form following a pilot study. Variables with more
than 80% missing information were not included. Records were
assessed by one of three medically-trained investigators and forms
were reviewed for missing data and consistency. Data were
entered twice into a computer database and EpiInfo validate
module was used to identify inconsistencies. VL diagnosis was
established either by confirmatory tests or by clinical and
epidemiological criteria. The laboratory tests could be any one
of the following: a positive Giemsa-stained bone marrow smear, a
titer $1:1,600 in direct agglutination test (DAT) or a titer $1:40
in indirect immunofluorescence test (IFI). Diagnosis based on
clinical and epidemiological criteria consisted of: a) clinical
features of VL (fever and hepatosplenomegaly) and b) pancytope-
nia; and c) a positive epidemiological history and d) clinical response
following a course of antimonials.
The weight/age Z scores (WAZ) were calculated using Nutrition
Program, EpiInfo (Centers for Disease Control and Prevention/World
Health Organization, 1978 reference). Children with WAZ ,23
were considered severely malnourished. Hemorrhagic manifestations
were divided into 2 groups: cutaneous (bruising and petechiae) and
mucosal (epistaxis and gengivorrhagia). Suspected bacterial co-
infection was considered when the attending physician prescribed
antibiotics and raised one of the following diagnoses: pneumonia,
gastroenteritis, sepsis, otitis media and skin abscess, according to locally
published guidelines [14]. Laboratory variables were categorized
according to the following cutoffp o i n t s :a )s e v e r el e u c o p e n i a( #2,500/
mm
3); severe neutropenia (neutrophil count #500/mm
3); b) severe
anemia (hemoglobin ,5 g/dL); and c) severe thrombocytopenia
(platelet count ,50,000/mm
3).
Sample size
A sample size calculation was performed in EpiInfo software.
Assumptions were inferred from preliminary analysis of the first
150 patients and included an unexposed : exposed ratio of 2:1 and
a death rate of 5% in non-exposed. A total of 429 children would
be required to detect a 2.5 increase in risk, with significance level
of 5% and power of 80%.
Statistical methods
Statistical analysis was performed using Epi-Info and STATA
software packages. First, Chi-square tests were used to test the
association between death and clinical, socio-demographic and
laboratory variables in order to select those significant at a p level
of ,0.2 for inclusion in the logistic regression model in a stepwise
backwards procedure. Variables showing an independent associ-
ation with the risk of dying at the p,0.05 level remained in the
final model.
The factors above listed as independent predictors of death from
VL were used to build a prognostic score. All regression
coefficients were divided by the lowest one (suspected bacterial
co-infection) and rounded to the next integer without decimal
points in order to facilitate clinical use. Subsequently, we validated
the new scoring system with all the patients included in this study:
the real outcome of each participant was compared to his/her
prediction based on the new scoring system. Sensitivity, specificity,
positive and negative predictive values and the area below the
receiver operating characteristic curve (ROC) were calculated and
used to evaluate the predictive performance of the prognostic score
[15]. ROC reflects the ability of a scoring system to differentiate
positive events (in this case, death in VL patients) and negative
events (no death in VL patients). A higher ROC represents a
better scoring system.
Results
Between May 1996 and June 2006 a total of 557 patients were
notified to the hospital epidemiology department as having a
diagnosis of VL. Four records were not found and other 7 were
excluded because, despite being initially notified as cases of VL,
later had an alternative diagnosis (such as leukemia). Therefore,
546 patients are reported here. Out of these, 385 had diagnosis
confirmed by a positive bone marrow smear, 14 by a positive DAT
Author Summary
Visceral leishmaniasis (VL) is a deadly disease caused by a
protozoan called Leishmania. It is transmitted to humans
from infected animals by a sandfly bite. Most people
actually manage to control the infection and do not get
sick, while others develop a range of symptoms. VL impairs
the production of blood components and causes the
immune system to malfunction, thus anemia, bleeding,
and bacterial infections often complicate the disease and
can lead to death. To identify risk factors for death from VL,
the authors studied 546 children in a referral center in
Recife, Brazil. They looked at clinical history, physical
examination and full blood counts on the assumption
these could be easily assessed in peripheral health
facilities. They found that the presence of fast breathing,
jaundice, mucosal (e.g. gum) bleeding and bacterial
infections would each increase the risk of death in three
to four-fold. The presence of very low counts of
neutrophils and platelets would increase the risk of death
in three and 12-fold respectively. This knowledge can help
clinicians to anticipate the use of antibiotics or transfusion
of blood products in high risk patients, who would
potentially benefit from transfer to centers with advanced
life support facilities.
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clinical and epidemiological criteria.
Out of 546 patients, 275 (50%) patients were male. The median
age was 3.2 years and the youngest child was four months-old and
the eldest 13.7 years-old on admission. The median duration of
symptoms was 30 days (interquartile range, 15–60 days). There
were 57 deaths, with a case-fatality rate of 10%. The main
immediate causes of death were associated bacterial infections in
21 (37%) cases, mucosal bleeding in 17 (29%), both infection and
bleeding in 10 (18%) and infection or bleeding associated with
liver failure in 8 (13%) and other causes in 2 (3%).
Onunivariate analysis (table 1), male gender,age less than five years-
old, severe malnutrition, presence of diarrhea, edema, bleeding
(cutaneous and mucosal), jaundice, dyspnea, suspected bacterial
co-infection, hemoglobin ,5 g/dL, leukocyte count ,2,500/mm
3,
neutrophil count ,500/mm
3 and platelet count ,50,000/mm
3 were
associated with risk of death with a p value ,0.2 and were selected for
inclusion in the multivariate logistic regression analysis.
Results of multivariate logistic regression analysis are shown on
table 1. The presence of mucosal bleeding, jaundice, dyspnea,
suspected bacterial co-infection, severe neutropenia (neutrophil
count ,500/mm
3) and severe thrombocytopenia (platelet count ,
50,000/mm
3) were identified as independent predictors of death
from VL. Severe thrombocytopenia showed the strongest
association with death (adjusted OR 11.7). The interactions
between ‘‘mucosal bleeding’’ and ‘‘thrombocytopenia’’ as well as
‘‘neutropenia’’ and ‘‘suspected bacterial co-infection’’ were tested,
but no statistically significant interactions were found (p=0.21 and
p=0.11 respectively).
The generated scoring system (table 2) consisted in allocating
the following points for each variable when present: one for
dyspnea, suspected bacterial co-infection and severe neutropenia;
two for mucosal bleeding and jaundice; three for severe
thrombocytopenia. Any patient could have a score ranging from
0 to 9. A score $3 was selected as the best predictor of death
because it was able to gather the most adequate combination of
sensitivity (88.7%), specificity (78.5%), positive predictive value
(32.0%), negative predictive value (78.5%) and area under ROC
curve (89.5%).
Discussion
The present study describes four clinical (mucosal bleeding,
jaundice, dyspnea, suspected bacterial co-infection) and two
laboratory variables (severe neutropenia and severe thrombocyto-
penia) as independent predictors of the risk of death in children
and adolescents younger than 15 years of age admitted for VL
treatment in a tertiary hospital in northeast Brazil.
Table 1. Factors associated with death from visceral leishmaniasis in children (univariate and multivariate analysis).
Variable
Dead(57)
n(%)
Alive(489)
n(%)
OR
(95% CI) Adjusted OR (95% CI)
Clinical/demographic
Male sex 20(35) 255(52) 0.53 (0.3–1.0)
Age ,5 years old 47(82) 323(66) 3.19 (1.4–7.5)
Severely malnourished* 8(14) 41(8) 1.78 (0.7–4.2)
Diarrhea 11(19) 62(13) 1.73 (0.8–3.7)
Edema 27(47) 69(14) 5.87 (3.1–11.1)
Jaundice 16(28) 22(5) 8.71 (3.9–19.1) 4.4 (1.7–11.2)
Dyspnea 24(42) 61(13) 5.43 (2.8–10.3) 2.8 (1.2–6.1)
Mucosal bleeding 10(17) 10(2) 10.69 (3.7–28.2) 4.1 (1.3–13.4)
Cutaneous bleeding 18(32) 31(6) 6.82 (3.3–14.0)
Upper gastrointestinal bleeding 4(7) 1(0.2) 38.27 (-)
Associated infections 23(40) 56(11) 5.56 (2.9–10.7) 2.7 (1.2–6.1)
Laboratory
{
Total leukocyte count
,2,500/mm
3
21(37) 142(29) 1.41 (0.8–2.6)
Total platelet count
,50,000/mm
3
43(75) 90(18) 15.01 (7.3–31.4) 11.7 (5.4–25.1)
Neutrophil count
,500/mm
3
17(30) 66(14) 2.68 (1.4–5.2) 3.1 (1.4–6.9)
Hemoglobin ,5 g/dL 31(54) 103(21) 4.43 (2.4–8.1)
*Weight not available for 2 children.
{Full blood count missing for 3children.
doi:10.1371/journal.pntd.0000877.t001
Table 2. Prognostic scoring system.
Variable Score
Dyspnea 1
Associated infections 1
Neutrophil count ,500/mm
3 1
Jaundice 2
Mucosal bleeding 2
Total platelet count ,50,000/mm
3 3
Allocate the points above for each variable when present.
doi:10.1371/journal.pntd.0000877.t002
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assessed in four studies from Africa [10–13] and one from Latin
America [5]. Only one of them, from Tunisia, exclusively analyzed
the pediatric age [10]. A total of 232 children were retrospectively
evaluated and seven prognostic factors at hospital admission were
identified: visit delayed more than 56 days, fever lasting more than
21 days, normal or low temperature (, 37,5uC according to the
authors), hemorrhagic syndrome, hemoglobin rate ,5.5 g/dL,
sedimentation rate ,25 mm and hypoalbuminemia ,30 g/L
[10]. We found three large studies from the Sudan and Uganda
[11–13]. In each of them more than 1,000 patients from all age
groups were included, but only one described risk factors
according to age group [11]. In the subset of Sudanese patients
younger than 16 years the following risk factors for death were
identified: age ,2 years, malnutrition (weight for height ,60%),
anemia (hemoglobin level ,6 g/dL) and splenomegaly (Hackett
grade 3–5)[11]. In a study from the Northeast of Brazil (Teresina,
Piauı ´) both children and adults were included in a case-control
study. Diarrhea, jaundice, fever for more than 60 days and
hematocrit #20% were found to be significantly associated with
death from VL in a multiple logistic regression model [5].
Out of the six factors identified in the present study, only
jaundice and hemorrhagic syndrome were previously reported by
other groups [5,10]. These heterogeneous findings could be
explained by the diversity of participants included in the different
studies regarding age, access to treatment, setting and Leishmania
species.
An interesting observation is that a higher risk of death was
associated with upper gastrointestinal (UGI) bleeding (OR=38.3,
95% CI not calculable) on bivariate analysis, but this did not
remain significant on multivariate analysis, probably due to the
small (5) number of children with UGI bleeding. Thrombocyto-
penia, but not decreased hemoglobin level was associated with
higher risk of death. Although UGI bleeding can be associated
with low platelet count or decreased hemoglobin level, respectively
as a cause and consequence of bleeding, we were not able to
analyze serial blood samples for each patient and only admission
samples were included in the model.
The newly generated prognostic scoring system is based on four
clinical variables and two laboratorial tests that are usually
available in poor resource settings. In addition, it demonstrated
satisfactory sensitivity and specificity similarly to those reported in
the study held in Teresina, Brazil (sensitivity 85.7% and specificity
92.5%) which also created a prognostic score for children and
adults with VL [5].
Our study had limitations that deserve to be discussed. Inherent
toretrospectivestudies,clinicalandlaboratorydata recordingmight
be lessaccurate,eventhough our studywascarried outina teaching
hospital with regular monitoring of medical recording quality. We
have decided to include cases with clinical-epidemiological
diagnoses, as well as those with confirmatory tests. While restricting
analysis to confirmed cases would be a methodologically interesting
option, in real life many cases do not have parasitological
confirmation. On the other hand, the case fatality rate (10%)
observed in our study was somewhat higher than the national
average of 7% [16] and this might be due to the characteristics of
this referral hospital that tends to receive cases from the most severe
spectrum of disease. The main immediate causes of death were
infections and bleeding which are the classical complications of the
disease and also compatible with results obtained from other groups
in different populations [5,10–12].
Despite these limitations, no previous reports have assessed
children-specific independent predictors for death by VL in Latin
America. The prognostic score reported in the present study can
be promptly assessed in any setting and require only trained health
care professionals, therefore are feasible in developing countries
where VL is endemic. Furthermore, the laboratory analyses are
simple and relatively cheap and can be performed in most health
facilities. Isolated risk factors or a combination of them may lead to
important clinical decisions such as: platelet or plasma transfusion,
use of antibiotics or use of vitamin K. In addition, early
identification of unfavorable prognostic factors can facilitate
rational allocation of VL cases to be treated as outpatients,
admitted to regional hospitals or referred to larger centers with
intensive care facilities. Prognostic and severity markers can also
be useful for the selection of candidates for clinical trials.
Visceral leishmaniasis is a model for the study of host-pathogen
interaction. The biological rationale to explain why some infected
individuals will develop any disease instead of asymptomatic
seroconversion remains unclear. A similar uncertainty involves
understanding the reasons behind a milder or more severe clinical
presentation. The predictors of death identified in the present
study (jaundice, dyspnea, suspected bacterial co-infection, mucosal
bleeding, severe neutropenia and severe thrombocytopenia) can be
associated with an aggressive bone marrow involvement, but also
seem to be proxy of a systemic, severe, imbalanced response to the
pathogen.
Although predictors can help identifying higher risk patients,
thus informing practice, studies addressing earlier risk markers
would be welcomed. The role of genetic susceptibility and
epigenetic interactions modulating host inflammatory response
needs further understanding.
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